3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide

C102H108N20O7S2 — CID 161480210

IUPAC3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide
SMILESCc1ccc(C(=O)NC2CC2)cc1-c1cn(-c2cnc3ccc(S(=O)(=O)C(C)(C)C)cn23)cn1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cnc3ccc(C(C)C)cn23)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cnc3ccc(C(O)C4CCCCC4)cn23)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cnc3ccc(SC4CCC4)cn23)c1
InChIInChI=1S/C28H31N5O2.C25H27N5O3S.C25H25N5OS.C24H25N5O/c1-18-7-8-20(28(35)31-23-10-11-23)13-24(18)22-14-30-33(17-22)26-15-29-25-12-9-21(16-32(25)26)27(34)19-5-3-2-4-6-19;1-16-5-6-17(24(31)28-18-7-8-18)11-20(16)21-14-29(15-27-21)23-12-26-22-10-9-19(13-30(22)23)34(32,33)25(2,3)4;1-16-5-6-17(25(31)28-19-7-8-19)11-22(16)18-12-27-30(14-18)24-13-26-23-10-9-21(15-29(23)24)32-20-3-2-4-20;1-15(2)18-6-9-22-25-12-23(28(22)13-18)29-14-19(11-26-29)21-10-17(5-4-16(21)3)24(30)27-20-7-8-20/h7-9,12-17,19,23,27,34H,2-6,10-11H2,1H3,(H,31,35);5-6,9-15,18H,7-8H2,1-4H3,(H,28,31);5-6,9-15,19-20H,2-4,7-8H2,1H3,(H,28,31);4-6,9-15,20H,7-8H2,1-3H3,(H,27,30)
InChIKeyWEGISSBHHJUNCH-UHFFFAOYSA-N
MW1790.25 g/mol
LogP18.50
Rot. Bonds22

About 3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide

3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide (PubChem CID 161480210) has the molecular formula C102H108N20O7S2 and a molecular weight of 1790.25 g/mol. Its IUPAC name is 3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide.

Molecular Properties

Compound Name3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide
PubChem CID161480210
Molecular FormulaC102H108N20O7S2
Molecular Weight1790.25 g/mol
Exact Mass1788.82
IUPAC Name3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide
SMILESCc1ccc(C(=O)NC2CC2)cc1-c1cn(-c2cnc3ccc(S(=O)(=O)C(C)(C)C)cn23)cn1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cnc3ccc(C(C)C)cn23)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cnc3ccc(C(O)C4CCCCC4)cn23)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cnc3ccc(SC4CCC4)cn23)c1
InChIInChI=1S/C28H31N5O2.C25H27N5O3S.C25H25N5OS.C24H25N5O/c1-18-7-8-20(28(35)31-23-10-11-23)13-24(18)22-14-30-33(17-22)26-15-29-25-12-9-21(16-32(25)26)27(34)19-5-3-2-4-6-19;1-16-5-6-17(24(31)28-18-7-8-18)11-20(16)21-14-29(15-27-21)23-12-26-22-10-9-19(13-30(22)23)34(32,33)25(2,3)4;1-16-5-6-17(25(31)28-19-7-8-19)11-22(16)18-12-27-30(14-18)24-13-26-23-10-9-21(15-29(23)24)32-20-3-2-4-20;1-15(2)18-6-9-22-25-12-23(28(22)13-18)29-14-19(11-26-29)21-10-17(5-4-16(21)3)24(30)27-20-7-8-20/h7-9,12-17,19,23,27,34H,2-6,10-11H2,1H3,(H,31,35);5-6,9-15,18H,7-8H2,1-4H3,(H,28,31);5-6,9-15,19-20H,2-4,7-8H2,1H3,(H,28,31);4-6,9-15,20H,7-8H2,1-3H3,(H,27,30)
InChIKeyWEGISSBHHJUNCH-UHFFFAOYSA-N
XLogP18.50
TPSA311.25 Ų
H-Bond Donors5
H-Bond Acceptors24
Rotatable Bonds22
Heavy Atoms131
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001790.25
LogP ≤ 518.50
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1024

Analyze 3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide?
The IUPAC name of 3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide (CID 161480210) is 3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide.
What is the SMILES notation for 3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide?
The canonical SMILES for 3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide is Cc1ccc(C(=O)NC2CC2)cc1-c1cn(-c2cnc3ccc(S(=O)(=O)C(C)(C)C)cn23)cn1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cnc3ccc(C(C)C)cn23)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cnc3ccc(C(O)C4CCCCC4)cn23)c1.Cc1ccc(C(=O)NC2CC2)cc1-c1cnn(-c2cnc3ccc(SC4CCC4)cn23)c1.
What is the InChIKey of 3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide?
The InChIKey is WEGISSBHHJUNCH-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H31N5O2.C25H27N5O3S.C25H25N5OS.C24H25N5O/c1-18-7-8-20(28(35)31-23-10-11-23)13-24(18)22-14-30-33(17-22)26-15-29-25-12-9-21(16-32(25)26)27(34)19-5-3-2-4-6-19;1-16-5-6-17(24(31)28-18-7-8-18)11-20(16)21-14-29(15-27-21)23-12-26-22-10-9-19(13-30(22)23)34(32,33)25(2,3)4;1-16-5-6-17(25(31)28-19-7-8-19)11-22(16)18-12-27-30(14-18)24-13-26-23-10-9-21(15-29(23)24)32-20-3-2-4-20;1-15(2)18-6-9-22-25-12-23(28(22)13-18)29-14-19(11-26-29)21-10-17(5-4-16(21)3)24(30)27-20-7-8-20/h7-9,12-17,19,23,27,34H,2-6,10-11H2,1H3,(H,31,35);5-6,9-15,18H,7-8H2,1-4H3,(H,28,31);5-6,9-15,19-20H,2-4,7-8H2,1H3,(H,28,31);4-6,9-15,20H,7-8H2,1-3H3,(H,27,30).
What are the key properties of 3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide?
3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide has a molecular weight of 1790.25 g/mol, XLogP of 18.50, 22 rotatable bonds, 5 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[1-(6-tert-butylsulfonylimidazo[1,2-a]pyridin-3-yl)imidazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-(6-cyclobutylsulfanylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;3-[1-[6-[cyclohexyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]pyrazol-4-yl]-N-cyclopropyl-4-methylbenzamide;N-cyclopropyl-4-methyl-3-[1-(6-propan-2-ylimidazo[1,2-a]pyridin-3-yl)pyrazol-4-yl]benzamide is sourced from PubChem (CID 161480210), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).